Proteogenomic Characterization of Endometrial Carcinoma

Yongchao Dou,Emily A Kawaler,Daniel Cui Zhou,Marina A Gritsenko,Chen Huang,Lili Blumenberg,Alla Karpova,Vladislav A Petyuk,Sara R Savage,Shankha Satpathy,Wenke Liu,Yige Wu,Chia-Feng Tsai,Bo Wen,Zhi Li,Song Cao,Jamie Moon,Zhiao Shi,MacIntosh Cornwell,Matthew A Wyczalkowski,Rosalie K Chu,Suhas Vasaikar,Hua Zhou,Qingsong Gao,Ronald J Moore,Kai Li,Sunantha Sethuraman,Matthew E Monroe,Rui Zhao,David Heiman,Karsten Krug,Karl Clauser,Ramani Kothadia,Yosef Maruvka,Alexander R Pico,Amanda E Oliphant,Emily L Hoskins,Samuel L Pugh,Sean J I Beecroft,David W Adams,Jonathan C Jarman,Andy Kong,Hui-Yin Chang,Boris Reva,Yuxing Liao,Dmitry Rykunov,Antonio Colaprico,Xi Steven Chen,Andrzej Czekański,Marcin Jędryka,Rafał Matkowski,Maciej Wiznerowicz,Tara Hiltke,Emily Boja,Christopher R Kinsinger,Mehdi Mesri,Ana I Robles,Henry Rodriguez,David Mutch,Katherine Fuh,Matthew J Ellis,Deborah DeLair,Mathangi Thiagarajan,D R Mani,Gad Getz,Michael Noble,Alexey I Nesvizhskii,Pei Wang,Matthew L Anderson,Douglas A Levine,Richard D Smith,Samuel H Payne,Kelly V Ruggles,Karin D Rodland,Li Ding,Bing Zhang,Tao Liu,David Fenyö,Clinical Proteomic Tumor Analysis Consortium,Anupriya Agarwal,Meenakshi Anurag,Dmitry Avtonomov,Chet Birger,Michael J Birrer,Simina M Boca,William E Bocik,Uma Borate,Melissa Borucki,Meghan C Burke,Shuang Cai,Anna Calinawan,Steven A Carr,Sonya Carter,Patricia Castro,Sandra Cerda,Michelle Chaikin,Daniel W Chan,Doug Chan,Alyssa Charamut,Feng Chen,Jin Chen,Lijun Chen,Lin S Chen,David Chesla,Milan G Chheda,Arul M Chinnaiyan,Shrabanti Chowdhury,Marcin P Cieslik,David J Clark,Sandra Cottingham,Houston Culpepper,Jacob Day,Stephanie De Young,Emek Demir,Saravana Mohan Dhanasekaran,Rajiv Dhir,Marcin J Domagalski,Peter Dottino,Brian Druker,Elizabeth Duffy,Maureen Dyer,Nathan J Edwards,Robert Edwards,Kim Elburn,Jayson B Field,Alicia Francis,Stacey Gabriel,Yifat Geffen,Daniel Geiszler,Michael A Gillette,Andrew K Godwin,Pamela Grady,Linda Hannick,Pushpa Hariharan,Sue Hilsenbeck,Barbara Hindenach,Katherine A Hoadley,Runyu Hong,Galen Hostetter,James J Hsieh,Yingwei Hu,Michael M Ittmann,Eric Jaehnig,Scott D Jewell,Jiayi Ji,Corbin D Jones,Renee Karabon,Karen A Ketchum,Munziba Khan,Beom-Jun Kim,Azra Krek,Tanya Krubit,Chandan Kumar-Sinha,Felipe D Leprevost,Michael Lewis,Qing Kay Li,Yize Li,Hongwei Liu,Jan Lubinski,Weiping Ma,Rashna Madan,Ewa Malc,Anna Malovannaya,Sailaja Mareedu,Sanford P Markey,Annette Marrero-Oliveras,John Martignetti,Jason McDermott,Peter B McGarvey,John McGee,Piotr Mieczkowski,Francesmary Modugno,Rebecca Montgomery,Chelsea J Newton,Gilbert S Omenn,Amanda G Paulovich,Amy M Perou,Francesca Petralia,Paul Piehowski,Larisa Polonskaya,Liqun Qi,Shannon Richey,Karna Robinson,Nancy Roche,Daniel C Rohrer,Eric E Schadt,Michael Schnaubelt,Yan Shi,Tara Skelly,Lori J Sokoll,Xiaoyu Song,Stephen E Stein,James Suh,Donghui Tan,Darlene Tansil,Guo Ci Teo,Ratna R Thangudu,Cristina Tognon,Elie Traer,Jeffrey Tyner,Ki Sung Um,Dana R Valley,Negin Vatanian,Pankaj Vats,Uma Velvulou,Michael Vernon,Liang-Bo Wang,Ying Wang,Alex Webster,Thomas Westbrook,David Wheeler,Jeffrey R Whiteaker,George D Wilson,Yuriy Zakhartsev,Robert Zelt,Hui Zhang,Yuping Zhang,Zhen Zhang,Grace Zhao
DOI: https://doi.org/10.1016/j.cell.2020.01.026
IF: 64.5
2020-02-20
Cell
Abstract:We undertook a comprehensive proteogenomic characterization of 95 prospectively collected endometrial carcinomas, comprising 83 endometrioid and 12 serous tumors. This analysis revealed possible new consequences of perturbations to the p53 and Wnt/β-catenin pathways, identified a potential role for circRNAs in the epithelial-mesenchymal transition, and provided new information about proteomic markers of clinical and genomic tumor subgroups, including relationships to known druggable pathways. An extensive genome-wide acetylation survey yielded insights into regulatory mechanisms linking Wnt signaling and histone acetylation. We also characterized aspects of the tumor immune landscape, including immunogenic alterations, neoantigens, common cancer/testis antigens, and the immune microenvironment, all of which can inform immunotherapy decisions. Collectively, our multi-omic analyses provide a valuable resource for researchers and clinicians, identify new molecular associations of potential mechanistic significance in the development of endometrial cancers, and suggest novel approaches for identifying potential therapeutic targets.
What problem does this paper attempt to address?